CHINARES PHARMA(03320): Dong-E-E-Jiao's net profit attributable to shareholders in 2025 is estimated to be approximately 1.739 billion yuan, an increase of 11.66% year-on-year.

21:23 19/03/2026

CITIC Pharmaceuticals (03320) announced the performance of Dong'e Ejiao in 2025, with total operating income of approximately 6.7 billion yuan, a year-on-year increase of 8.83%; the net profit attributable to shareholders of the listed company is approximately 1.739 billion yuan, a year-on-year increase of 11.66%; the basic earnings per share is 2.7 yuan, and a cash dividend of 14.31 yuan (including tax) is proposed for every 10 shares.

CHINARES PHARMA (03320) announced the performance of Dong-E-E-Jiao in 2025, with total operating income of approximately 6.7 billion yuan, a year-on-year increase of 8.83%; the net profit attributable to shareholders of the listed company is approximately 1.739 billion yuan, a year-on-year increase of 11.66%; basic earnings per share is 2.7 yuan, intending to distribute a cash dividend of 14.31 yuan (including tax) for every 10 shares.

Ye Xing Group (01941) expects the company's owners' share of profit and comprehensive income in 2025 to be approximately 10.7 million to 15.7 million yuan, turning a loss into a profit compared to the previous year.

ZHUGUANG HOLD (01176) delayed the release of the full-year performance forecast for 2025 and expected suspension of trading from April 1st.

CHINNEY ALLI (00385) Has Issued a Profit Warning, Anticipating a Year-on-Year Decrease in Net Profit for 2025 of no more than 65%

ZHUGUANG HOLD (01176) delayed the release of the full-year performance forecast for 2025 and expected suspension of trading from April 1st.

CHINNEY ALLI (00385) Has Issued a Profit Warning, Anticipating a Year-on-Year Decrease in Net Profit for 2025 of no more than 65%